DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

LinksSchließen

Referenz

Granger CB, Lopes RD, Hanna M. et al.
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.

Am Heart J 2015;
169 (01) 25-30

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: